Natixis’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.2M Sell
8,704
-32,769
-79% -$8.7M 0.02% 472
2026
Q1
$4.55M Buy
+41,473
New +$5.91M 0.02% 448
2025
Q4
– Sell
-264,009
Closed -$51.7M – 1334
2025
Q3
$51.7M Buy
264,009
+263,685
+81,384% +$43.4M 0.24% 64
2025
Q2
$29.3K Sell
324
-198,868
-100% -$15.7M ﹤0.01% 912
2025
Q1
$11.6M Buy
199,192
+80,245
+67% +$7.42M 0.06% 206
2024
Q4
$15.8M Buy
+118,947
New +$11.2M 0.1% 157

Other funds holding ALAB

Natixis's ALAB Position: Q2 2026 in Review

Natixis reduced its Astera Labs (ALAB) stake by 79% in Q2 2026, selling an estimated $8.7M and leaving 8,704 shares worth $4.2M. The position accounts for 0.02% of the portfolio, ranked #472.

Natixis first reported a position in ALAB in Q4 2024 and has held it in 6 quarters since. The position peaked at $51.7M in Q3 2025. 993 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Natixis held 8,704 shares of Astera Labs worth $4.2M as of Q2 2026.
  • Natixis sold 32,769 Astera Labs shares in Q2 2026, an estimated $8.7M.
  • Astera Labs made up 0.02% of Natixis's portfolio in Q2 2026, its #472 holding.
  • Natixis first reported a position in Astera Labs in Q4 2024 and has held it in 6 quarters since.
  • Natixis's Astera Labs position peaked at $51.7M in Q3 2025.
  • 993 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.